HHS
Trump Nominates Dr. Heidi Overton as FDA Commissioner
President Donald Trump announced his nomination of Heidi Overton, MD, PhD as the commissioner for the U.S. Food and Drug Administration (FDA). Overton would replace Dr. Marty Makary who resigned in May 2026. Kyle Diamantas, JD, has been serving as acting commissioner. Overton is a physician and health care policy leader currently served as deputy assistant to ...
Associations Respond to Mandatory GRAS Notification Proposal
The U.S. Department of Health and Human Services (HHS) and U.S. Food and Drug Administration (FDA) proposed a rule requiring manufacturers to notify FDA whenever they conclude the use of a substance added to human or animal food is generally recognized as safe (GRAS). Since Congress established the GRAS exemption in 1958, manufacturers have been ...
FDA Approves 3 Food Colors From Natural Sources
On May 9, the U.S. Food and Drug Administration (FDA) announced it granted three new color additive petitions that will expand the palette of available colors from natural sources for manufacturers to safely use in food. “Today we take a major step to Make America Healthy Again,” said U.S. Department of Health and Human Services (HHS) ...
HHS, FDA Phasing Out Petroleum-based Synthetic Food Dyes, Industry Responds
On April 22, the U.S. Food and Drug Administration (FDA) and Department of Health and Human Services (HHS) announced a plan to phase out all petroleum-based synthetic dyes from the nation’s food supply as part of the Make America Healthy Again (MAHA) movement. FDA is taking numerous actions including establishing a national standard and timeline ...
Trade Associations Congratulate RFK Jr. on HHS Secretary Confirmation
On Feb. 13, politician and environmental attorney Robert F. Kennedy Jr. (RFK) was confirmed as the next Secretary of Health and Human Services (HHS). The Natural Products Association (NPA), the Council for Responsible Nutrition (CRN), the American Herbal Products Association (AHPA) and the Consumer Healthcare Products Association (CHPA) congratulated Kennedy on his confirmation and expressed ...
CRN Encourages Greater Inclusion of Supplements in Dietary Guidelines
According to CRN, the report revealed troubling trends, particularly how Americans’ diets consistently fall short of aligning with Dietary Guidelines recommendations, leading to increased risk of nutrient deficiencies. Some of these shortfalls—such as vitamin D, calcium, potassium and dietary fiber—pose significant public health concerns due to potential adverse health effects. Certain population groups, such as pregnant individuals, face additional risks due to inadequate ...
Industry Responds to Dr. Marty Makary’s Nomination as FDA Commissioner
On Nov. 22, President-elect Donald Trump nominated Dr. Marty Makary as commissioner for the U.S. Food and Drug Administration (FDA). He would succeed outgoing FDA Commissioner Robert Califf. Makary is a surgical oncologist at Johns Hopkins Hospital in Baltimore, MD. He is also a professor at the Johns Hopkins School of Medicine, a researcher, an ...
NPA Issues Statement in Response to FDA’s Refusal to Hold Public Hearing Regarding NMN
On July 20, the U.S. Food and Drug Administration (FDA) rejected a request by Rep. Jeff Duncan (R-SC), a member of the House Energy and Commerce Committee, to hold a public hearing on the agency’s position on nicotinamide mononucleotide (NMN). FDA stated that a public comment period would be sufficient. In response, the Natural Products ...
Durbin, Braun Introduce Legislation to Mandate Product Listings for Dietary Supplements
U.S. Senate Majority Whip Dick Durbin (D-IL) and U.S. Senator Mike Braun (R-IN) introduced the Dietary Supplement Listing Act of 2022, bipartisan legislation to require dietary supplement manufacturers to list their products with the U.S. Food and Drug Administration (FDA). The Dietary Supplement Listing Act of 2022 would require companies to provide FDA with vital information about their ...
NPA Files Citizen’s Petition With FDA on Specific CBD Relief
On Feb. 22, in a Citizen’s Petition to the U.S. Food and Drug Administration (FDA), the Natural Products Association (NPA) requested the FDA either: Determine cannabidiol (CBD) is not excluded from the definition of a dietary supplement under 21 U.S.C. §321(ff)(3)(B) allowing the Commissioner the ability to exercise enforcement discretion in a specific and selective ...
Don't Miss Out!
Industry Professionals
Stay Informed!
Stay informed about the latest health, nutrition, and wellness developments by signing up for a FREE subscription to Nutrition Industry Executive magazine and digital newsletter.
Once subscribed, you will receive industry insights, product trends, and important news directly to your doorstep and inbox.
Featured Listings:
